Your session is about to expire
← Back to Search
Behavioural Intervention
Exercise Snacks for Type 2 Diabetes
N/A
Recruiting
Led By Jonathan Little, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Aged 30-75 years
Have physician-diagnosed type 2 diabetes
Must not have
Prescribed beta-blockers that can compromise the validity of heart rate measurements during the submaximal exercise test
Currently diagnosed with a cardiac or pulmonary disease (e.g., angina, arrhythmia, exercise-induced bronchospasm) that would prevent exercise participation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-12 weeks
Summary
This trial will test if a 12-week exercise program using technology is possible for adults with type 2 diabetes in a real-world setting. The study will also look at how well the program works in
Who is the study for?
Adults aged 30-75 with type 2 diabetes, HbA1c ≤8.5%, physically inactive, and not on extreme diets or certain medications can join this study. They must be able to use technology for the program and not have conditions like severe heart disease, recent cardiovascular events, or psychiatric disorders that interfere with exercise.
What is being tested?
The trial is testing 'exercise snacks,' short bursts of physical activity facilitated by technology over a period of 12 weeks. Participants are randomly placed into two groups: one doing these exercises and another performing placebo activities to compare effects on blood sugar control and fitness.
What are the potential side effects?
Since the intervention involves light to moderate exercise, potential side effects may include typical exercise-related discomforts such as muscle soreness or fatigue. However, serious side effects are unlikely given the eligibility criteria screening for pre-existing health issues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 30 and 75 years old.
Select...
I have been diagnosed with type 2 diabetes by a doctor.
Select...
I am on 2 or fewer heart-related medications.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am taking beta-blockers that may affect heart rate tests.
Select...
I have a heart or lung condition that stops me from exercising.
Select...
My blood pressure is not higher than 160/90 mmHg.
Select...
I have a surgery planned in the next 3-4 months that will stop me from exercising.
Select...
I have not donated more than a pint of blood in the last month.
Select...
I am currently on dialysis.
Select...
I have conditions like diabetic ulcers or neuropathy that stop me from exercising.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ na (recruitment period)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~na (recruitment period)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Determine the number and percentage of participants retained after the 12-week intervention
Determine the number of eligible individuals who would be willing to take part in this trial
Determine the number of individuals living with type 2 diabetes that are eligible to participate in the trial
+1 moreSecondary study objectives
Change in 24h glucose concentration
Change in blood lipid profile measured before and after the 12-week intervention
Change in blood pressure measured before and after the 12-week intervention
+11 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise SnacksExperimental Treatment1 Intervention
Vigorous-intensity bodyweight exercises performed 4 times per day on at least 5 days per week.
Group II: Placebo ExerciseActive Control1 Intervention
Low-intensity stretching exercises performed 4 times per day on at least 5 days per week.
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,481 Previous Clinical Trials
2,494,836 Total Patients Enrolled
McMaster UniversityOTHER
918 Previous Clinical Trials
2,616,213 Total Patients Enrolled
Jonathan Little, PhDPrincipal InvestigatorUniversity of British Columbia
6 Previous Clinical Trials
265 Total Patients Enrolled